It was another tense week on Wall Street as investors digested fresh commentary from Federal Reserve Chair Janet Yellen. Once again, Ukraine tensions made their way into the headlines, but that did not derail Russian stocks from posting a 10-day winning streak.
Even with a loss of about 2% on Friday, the Market Vectors Russia ETF (RSX) was able to notch a modest weekly gain. Here in the U.S., the S&P 500 and the Dow Jones Industrial posted solid weekly performances before backing off of record highs on Friday. The PowerShares QQQ (QQQ) , the NASDAQ-100 tracking ETF), added over 1% on the week, indicating some investors continue to be comfortable taking on risk with biotechnology and technology fare.
With those factors in mind, let’s have a look at some of the week’s biggest ETF stories.
Broad Market and Sector ETFs
Apple’s rise lifts a plethora of ETFs. [Apple's Rise Buoys These ETFs]
In an encouraging sign for risk appetite, NASDAQ ETFs have taken on a noteworthy leadership role.
The biotech ETF bubble that never really materialized.
What Wall Street is ignoring with shares of WisdomTree. [Global Markets Could Power Shares of WisdomTree]
What makes this beloved dividend ETF tick. [A Look at a Beloved Dividend ETF]
A look at Vanguard’s ascent to $3 trillion in assets under management. Hint: It’s not all about ETFs.
Believe it: Bank ETFs are back in style.
This combination emerging/frontier markets ETF is on the move…higher. [Frontier ETF Asserts Itself]
This India ETF could be nearing a buy point.
Good deals to be had with global energy ETFs. [Bargains With Global Energy ETFs]
Europe’s avenues for dividend growth.
Big PIMCO ETF feasts on investment-grade corporate debt.
With inflation benign, TIPS ETFs languish. [Low Inflation Hampers TIPS ETFs]
Stick with high-yield bonds with these ETFs.
Evaluating emerging markets bond ETFs.
ETF Trends editorial team contributed to this post. Tom Lydon’s clients own shares of QQQ.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.